A Truly Differentiated Imaging Leader for the Global Clinical Research Community

Learn More

Complete Radiopharmaceutical Therapy Solutions

Learn More

Complete Clinical Imaging Core Lab Capabilities

Learn More

Unmatched PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Gain New Insights in Early Drug Discovery

Learn More

TRP Annual Meeting 2024

While radioligand therapies have gained significant traction in recent years, Invicro has been dedicated to nuclear medicine for over two decades, leading the forefront of the radiopharmaceutical boom.
Your preclinical and clinical trials need Invicro as your scientific and operational collaborator. Let’s meet to discuss your RLT programs:

Let’s Chat

Pioneering BLI Research for 20+ Years

Premier Bioluminescence Imaging Services

Invicro has made a profound impact in the field of bioluminescence imaging (BLI) research for our pharma partners with our leadership being the first to bring this disrupting technology into the CRO space. The speed & precision of our image analytics and reporting, coupled with highly performing deep tissue tumor models has allowed us to stay at the forefront of this imaging modality.

Contact us to discuss BLI driven PK/PD or efficacy studies.

Let’s Chat

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,500+ Research Trials Managed
  • 535+ Clinical Trials Managed
  • 40,000,000+ (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now